ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Transvaginal Mesh Verdict: Texas Woman Awarded $73.5 Million from Boston Scientific

Gavel on cash, purple

A jury slapped a Massachusetts-based medical device company with an order to pay $73.5 million after finding that it was liable for leaving a woman in severe pain following a vaginal mesh implant.

A Texas jury awarded Martha Salazar $23 million in compensatory damages and $50 million in punitive damages from Boston Scientific, which manufactured the Obtryx bladder sling that caused Salazar’s permanent injuries.

A 42-year-old former property manager, Salazar said she could no longer walk or sit normally and suffered severe pain after she was implanted with the mesh sling intended to treat mild incontinence. Instead of finding relief, she suffered several internal injuries that required treatment of 42 additional procedures and four major surgeries.

“This woman was seeking help with minor urine leakage and wound up with a catastrophic, life-altering injury that required four major surgeries. It’s a tragedy that these slings are still on the market.” Salazar’s lawyer Dave Matthews told Bloomberg.

Critics of vaginal mesh hope the large punitive damages award deters the company and others like it from producing more dangerous devices. Mesh is long-used in medical procedures, but some question whether it was designed to support pelvic tissue.

Jury Finds Gross Negligence

After a two-week trial, the Dallas jury found Boston Scientific acted with gross negligence, and this allowed the award for punitive damages.

“Over a seven-year period, Boston Scientific failed to warn doctors and their patients of the serious complications associated with the Obtryx sling, even though the company was aware of the product’s problems,” Matthews said in a statement.

Salazar’s legal team presented evidence that the company was aware of the sling’s questionable safety record. This included an internal e-mail from a company executive to sales reps telling them to keep results of a company study questioning device safety from physicians.

Matthews asked for an award of $14 million, and the jury awarded $23 million after it found that the mesh sling was faulty and the company failed to warn doctors and patients.

Boston Scientific denies liability and plans to appeal. The company claimed Salazar failed to show at trial the mesh sling was “unreasonably dangerous,” the Minneapolis Star-Tribune reported.

It also faces about 23,000 additional mesh lawsuits and previously talked about negotiating settlements. This is the first trial loss for the device maker after winning its first two.

Award Is Largest to Date; Thousands More Lawsuits Pending

Salazar’s award is the largest to date out of the handful of cases tried in courts. Over 60,000 cases against a number of companies still await resolution.

Injured by complications related to Transvaginal Mesh? Get a Free Case Review

In an effort to resolve some claims, a number of mesh device makers decided to settle cases out of court.

American Medical Systems led the way by offering $830 million to settle its mesh injury claims. Coloplast settled its small amount of cases for $16 million.

Johnson & Johnson’s Ethicon unit has the largest number of federal lawsuits filed against it but refused to enter into settlement talks. The New Jersey-based drug giant lost a few cases already with awards in the millions. Just last week, a West Virginia jury ordered J&J to pay $3.27 million.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine

3 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Feeley, J. (2014, September 9). Boston Scientific ordered to pay $73 million over implant. Bloomberg, Retrieved from
  2. Dye, J. (2014, September 9). Boston Scientific ordered to pay $73 million over mesh device. Reuters. Retrieved from
  3. Carlson, L. (2014, September 10). Boston Scientific hit with $73.5 million jury verdict in mesh case. Minneapolis Star-Tribune. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(877) 312-3413